Skip to main content
. 2017 Sep 6;7:10656. doi: 10.1038/s41598-017-11152-w

Figure 3.

Figure 3

(A) SERS responses in the DA-1 chamber of microfluidic immunoassay during detection of IL-18 in human blood plasma sample according to the subsequent steps of parallel approach: (a) after the mixture of equal amounts of three kinds of Raman reporter-labeled Au nanoparticles was delivered and incubated (5 min) onto the anti-IL18 modified Ag-Au SERS-active surface; (b–f) after subsequent washing by PBS buffer solution. (B) Typical SERS responses for increasing concentration of target IL-6, IL-8, and IL-18 interleukins in blood plasma during a simultaneous multiplexed approach.